hydroxyproline has been researched along with triptolide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, K; Kumagai, N; Lu, Y; Nakamura, Y; Nishida, T; Seki, K | 1 |
| Chen, J; Huang, D; Huang, Y; Ke, J; Li, L; Liu, M; Wu, W | 1 |
2 other study(ies) available for hydroxyproline and triptolide
| Article | Year |
|---|---|
Inhibition by triptolide of IL-1-induced collagen degradation by corneal fibroblasts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Collagen; Collagenases; Cornea; Diterpenes; Epoxy Compounds; Fibrinolysin; Fibroblasts; Hydroxyproline; Immunoblotting; Interleukin-1; Male; Phenanthrenes; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Tripterygium | 2003 |
Triptolide alleviates isoprenaline-induced cardiac remodeling in rats via TGF-β1/Smad3 and p38 MAPK signaling pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Cardiotonic Agents; Diterpenes; Epoxy Compounds; Fibrosis; Hydroxyproline; Isoproterenol; Male; Myocardium; Organ Size; p38 Mitogen-Activated Protein Kinases; Phenanthrenes; Rats; Rats, Wistar; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ventricular Remodeling | 2015 |